| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Thomas E. PolenPresident, CEO & Chairman | -20.21k | 404.53k | Derivative Exercise and Sale | 126.16 - 146.35 | 110.16k | - |
| 2026-05-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75.00 | 11.05k | Automatic Disposition | 147.35 | 21.08k | -0.35% |
| 2026-04-27 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -74.00 | 11.24k | Automatic Disposition | 151.94 | 21.16k | -0.35% |
| 2026-04-06 | Ms. Shana Carol NealExec. VP & CPO | -1.15k | 0.00 | Sale to Issuer | - | 23.97k | -4.56% |
| 2026-03-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75.00 | 11.76k | Automatic Disposition | 156.83 | 21.23k | -0.35% |
| 2026-02-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75.00 | 13.64k | Automatic Disposition | 181.84 | 21.31k | -0.35% |
| 2026-02-18 | Mr. Bertram Lee ScottIndependent Director | -953.00 | 174.03k | 売り | 182.61 | 36.76k | -2.53% |
| 2026-01-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75.00 | 15.20k | Automatic Disposition | 202.73 | 16.43k | -0.45% |
| 2026-01-21 | Ms. Pamela L. Spiknerインサイダー | -84.00 | 0.00 | Sale to Issuer | - | 1.83k | -4.38% |
| 2026-01-15 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -3.05k | 125.49k | Derivative Exercise and Sale | 167.91 - 209.00 | 12.10k | - |
| 2026-01-15 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -1.01k | 208.61k | Automatic Disposition | 206.54 | 12.10k | -7.71% |
| 2026-01-03 | Mr. David Michel ShanExec. VP & Chief Integrated Supply Chain Officer | -44.00 | 0.00 | Sale to Issuer | - | 8.93k | -0.49% |
| 2025-12-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -74.00 | 14.51k | Automatic Disposition | 196.08 | 16.51k | -0.45% |
| 2025-12-17 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -629.00 | 123.30k | Automatic Disposition | 196.03 | 13.11k | -4.58% |
| 2025-12-01 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -75.00 | 14.50k | Automatic Disposition | 193.36 | 16.58k | -0.45% |
| 2025-11-26 | Mr. David Michel ShanExec. VP & Chief Integrated Supply Chain Officer | -134.00 | 0.00 | Sale to Issuer | - | 8.97k | -1.47% |
| 2025-11-26 | Ms. Shana Carol NealExec. VP & CPO | -2.45k | 0.00 | Sale to Issuer | - | 21.33k | -10.32% |
| 2025-11-26 | Mr. Roland GoetteExec. VP & President of EMEA | -138.00 | 0.00 | Sale to Issuer | - | 18.78k | -0.73% |
| 2025-11-26 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -1.77k | 0.00 | Sale to Issuer | - | 13.73k | -11.41% |
| 2025-11-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -419.00 | 0.00 | Sale to Issuer | - | 16.66k | -2.45% |
| 2025-11-26 | Mr. Christopher J. DelOreficeインサイダー | -4.25k | 0.00 | Sale to Issuer | - | 22.98k | -15.59% |
| 2025-11-26 | Mr. Richard E. Byrdインサイダー | -1.72k | 0.00 | Sale to Issuer | - | 13.85k | -11.04% |
| 2025-11-26 | Mr. Thomas E. PolenPresident, CEO & Chairman | -17.42k | 0.00 | Sale to Issuer | - | 105.47k | -14.18% |
| 2025-11-07 | Mr. Bertram Lee ScottIndependent Director | -217.00 | 38.32k | 売り | 176.58 | 35.82k | -0.60% |
| 2025-10-27 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -57.00 | 10.60k | Automatic Disposition | 186.01 | 8.25k | -0.69% |
| 2025-09-26 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -58.00 | 10.50k | Automatic Disposition | 181.03 | 8.30k | -0.69% |
| 2025-09-10 | Dr. Claire M. Fraser-Liggettインサイダー | -917.00 | 171.94k | 売り | 187.50 | 22.23k | -3.96% |
| 2025-09-01 | Mr. Christopher J. DelOreficeインサイダー | -278.00 | 0.00 | Sale to Issuer | - | 21.22k | -1.29% |
| 2025-09-01 | Mr. Richard E. Byrdインサイダー | -216.00 | 0.00 | Sale to Issuer | - | 6.74k | -3.11% |
| 2025-08-22 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -57.00 | 11.29k | Automatic Disposition | 197.99 | 8.36k | -0.68% |
| 2025-08-20 | Mr. Michael C. FeldExec. VP & Chief Revenue Officer | -773.00 | 0.00 | Sale to Issuer | - | 8.42k | -8.41% |
| 2025-08-11 | Mr. Gregory J. HayesIndependent Director | 5.25k | 1.01M | 買い | 191.57 | 5.25k | - |
| 2025-08-08 | Dr. Claire M. Fraser-Liggettインサイダー | -863.00 | 165.95k | 売り | 192.30 | 23.14k | -3.59% |
| 2025-07-18 | Mr. Michael GarrisonExec. VP & President of Medical Segment and BioPharma Systems Segments | -6.36k | 207.40k | Derivative Exercise and Sale | 147.68 - 181.50 | 4.89k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。